Skip to content

Rhinological Outcomes in Endonasal Pituitary Surgery

Rhinological Outcomes in Endonasal Pituitary Surgery: A Multi-Center Observational Cohort Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01504399
Enrollment
235
Registered
2012-01-05
Start date
2011-10-01
Completion date
2015-12-09
Last updated
2018-08-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acromegaly, Cushings Disease, Pituitary Adenoma, Pituitary Neoplasm, Prolactinoma

Keywords

Pituitary surgery, Transsphenoidal surgery, Anterior skull base surgery, Endoscopic surgery, Patient survey, Nasal complications

Brief summary

This is a prospective, multi-center observational study designed to address patient-reported nasal outcomes in adults undergoing endoscopic and microscopic surgical removal of pituitary tumors. The primary objective of this study is to determine the difference in nasal outcomes by using the Anterior Skull Base (ASK) Nasal survey between patients treated with endoscopic surgical technique and those treated with microscopic surgical technique. Patients will be given the ASK Nasal survey to assess their nasal functioning and overall health before their surgery, and at post-operative visits 1-2 weeks, 3 months, and 6 months.

Detailed description

The technical and patient factors that influence rhinological (nasal) outcomes following endonasal anterior skull base surgery and pituitary surgery are not well understood. Several timely and controversial topics, such as the influence of endoscopic techniques and the impact of underlying disease on nasal outcomes are in need of further study. The Anterior Skull Base (ASK) Nasal survey is a 24-item questionnaire designed to assess for common postoperative nasal complaints, such as crusting, nasal congestion, pain, sinusitis, sense of smell, and overall functioning. The survey is a brief and simple assessment that asks patients to score symptom severity on a five-point scale.

Interventions

None listed

Sponsors

St. Joseph's Hospital and Medical Center, Phoenix
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Pituitary tumor patients treated by transsphenoidal route * Adults (age 18-80 years) * Direct endonasal or endoscopic approach * Non-functioning adenoma, Cushing's disease, acromegaly

Exclusion criteria

* Patients treated by expanded endonasal approaches (transtubercular approach) * Sublabial approach

Design outcomes

Primary

MeasureTime frameDescription
ASK Nasal symptom severity scores and SF-8 scores3 monthsCompare symptom severity scores and quality of life scores in first-time surgery patients with nonfunctioning adenomas on the ASK Nasal and SF-8.
Validation of ASK Nasal survey tool3 monthsValidate a nasal outcomes scale (ASK Nasal) specifically designed for anterior skull base surgery.

Secondary

MeasureTime frameDescription
ASK Nasal symptom severity scores2 weeks, 3 months, 6 months postoperative* Evaluate the symptom severity scores on the ASK Nasal for first time surgery patients with nonfuctioning adenomas at the first post-operative visit and at 6 months. * Evaluate the symptom severity scores on the ASK Nasal for all patients at the first post-operative visit and at 6 months.
Impact of surgical techniques and complications on ASK Nasal scores6 months* Subgroup analysis on the impact of such surgical techniques, such as middle turbinate resection and nasal packing, on ASK Nasal scores will be performed. * Subgroup analysis of rhinological complications, such as sinusitis, on ASK Nasal scores. * Objective intranasal endoscopy findings at follow-up visits.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 23, 2026